10x Genomics (NASDAQ:TXG) Given New $18.00 Price Target at Morgan Stanley
10x Genomics (NASDAQ:TXG – Free Report) had its price target reduced by Morgan Stanley from $26.00 to $18.00 in a research note released on Monday,Benzinga reports. They currently have an overweight rating on the stock. TXG has been the subject of several other reports. The Goldman Sachs Group cut their price objective on 10x Genomics […]
10x Genomics (NASDAQ:TXG – Free Report) had its price target reduced by Morgan Stanley from $26.00 to $18.00 in a research note released on Monday,Benzinga reports. They currently have an overweight rating on the stock. TXG has been the subject of several other reports. The Goldman Sachs Group cut their price objective on 10x Genomics […]
